Affordable Access

Access to the full text

Second primary lung cancer in United States Cancer Survivors, 1992–2008

Authors
  • Donin, Nicholas M.1, 2
  • Kwan, Lorna1
  • Lenis, Andrew T.1
  • Drakaki, Alexandra3, 2
  • Chamie, Karim1, 2
  • 1 University of California, Department of Urology, David Geffen School of Medicine, Los Angeles, CA, USA , Los Angeles (United States)
  • 2 University of California, Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA , Los Angeles (United States)
  • 3 University of California, Department of Medicine, Division of Hematology & Oncology, David Geffen School of Medicine, Los Angeles, CA, USA , Los Angeles (United States)
Type
Published Article
Journal
Cancer Causes & Control
Publisher
Springer-Verlag
Publication Date
Mar 21, 2019
Volume
30
Issue
5
Pages
465–475
Identifiers
DOI: 10.1007/s10552-019-01161-7
Source
Springer Nature
Keywords
License
Yellow

Abstract

PurposeLung cancer is common and lethal, and can occur in survivors of previous cancers. We sought to describe the incidence and mortality attributable to second primary lung cancers (SPLC) among survivors of other cancers, and to identify survivors at highest risk.MethodsWe identified adults diagnosed with a localized malignancy from non-pulmonary cancer sites from surveillance, epidemiology, and end results (SEER) data from 1992 to 2008. We explored factors associated with the incidence and death from SPLC using bivariable and multivariable models. Finally, we compared standardized incidence rates for SPLC in our cohort with the control arm of the National Lung Screening Trial (NLST), a randomized lung cancer screening trial.ResultsWe identified 1,450,837 survivors of non-pulmonary cancers, of whom 25,472 developed SPLC at a mean (SD) follow-up of 5.7 (3.6) years. Over half (57%) of patients with SPLC died of the disease. Survivors of cancer of the hypopharynx, oropharynx, tonsil, and larynx, experienced SPLC at standardized incidence rates which greatly exceeded that observed in the control arm of the NLST (572/100,000 person-years). Additionally, survivors of bladder and esophageal cancer had rates that approached the NLST control arm rate. Increasing age and being divorced/widowed/separated were independent risk factors for SPLC in most primary cancer types.ConclusionThe incidence of SPLC in survivors of certain primary cancers greatly exceeds the rate observed in the control arm of the NLST. Further study could help determine if screening for lung cancer in these cancer survivors could prevent death from lung cancer.

Report this publication

Statistics

Seen <100 times